These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34933801)

  • 1. Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease.
    Huang MF; Lee WJ; Yeh YC; Lin YS; Lin HF; Wang SJ; Yang YH; Chen CS; Fuh JL
    J Formos Med Assoc; 2022 Sep; 121(9):1705-1713. PubMed ID: 34933801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
    Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
    Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
    J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
    Sannemann L; Schild AK; Altenstein S; Bartels C; Brosseron F; Buerger K; Cosma NC; Fliessbach K; Freiesleben SD; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kobeleva X; Laske C; Metzger CD; Munk MHJ; Perneczky R; Peters O; Polcher A; Priller J; Rauchmann B; Rösch C; Rudolph J; Schneider A; Spottke A; Spruth EJ; Teipel S; Vukovich R; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    Alzheimers Res Ther; 2020 Oct; 12(1):131. PubMed ID: 33066827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons.
    Liew TM
    J Am Med Dir Assoc; 2019 Aug; 20(8):1054.e1-1054.e9. PubMed ID: 30926409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.
    De Vito AN; Calamia M; Weitzner DS; Bernstein JPK;
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1627-1634. PubMed ID: 30276884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment.
    Lee YG; Park M; Jeong SH; Baik K; Kang S; Yoon SH; Na HK; Sohn YH; Lee PH
    Neurology; 2023 Sep; 101(12):e1186-e1195. PubMed ID: 37524535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia.
    Leoutsakos JS; Wise EA; Lyketsos CG; Smith GS
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1865-1873. PubMed ID: 31452260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis.
    Mallo SC; Patten SB; Ismail Z; Pereiro AX; Facal D; Otero C; Juncos-Rabadán O
    Ageing Res Rev; 2020 Mar; 58():101004. PubMed ID: 31881368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.
    Qiu J; Goldstein FC; Hanfelt JJ
    Am J Geriatr Psychiatry; 2022 Aug; 30(8):925-934. PubMed ID: 35067420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease.
    Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE;
    Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
    Cannizzaro A; Ronat L; El Haffaf LM; Hanganu A;
    Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5952. PubMed ID: 37351584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.